{"id":"W3027025576","doi":"10.1016/j.jval.2020.04.958","title":"PND66 RECENT EVOLUTION OF THE MARKET FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Teriflunomide; Fingolimod; Glatiramer acetate; Medical prescription; Dimethyl fumarate; Medicine; Multiple sclerosis; Ocrelizumab; Pediatrics; Family medicine; Internal medicine; Pharmacology; Psychiatry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006374966,0.00007899786,0.0002290399,0.00002770295,0.00007129516,0.000001924294,0.0001385684,0.0000656094,0.00002521917],"category_scores_gemma":[0.0006772268,0.00005807978,0.0000620695,0.0002023948,0.00004358701,0.0000152384,0.00003757758,0.0001311782,2.496269e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000517431,"about_ca_system_score_gemma":0.001214163,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3867463,"about_ca_topic_score_gemma":0.1459096,"domain_scores_codex":[0.9987534,0.0003564461,0.000368883,0.000196818,0.00003188176,0.0002925947],"domain_scores_gemma":[0.9990153,0.0006677869,0.0001140839,0.0001231357,0.00003429029,0.00004541764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01138916,0.0008878036,0.6054165,0.007421104,0.0002598992,0.000001599268,0.002808961,0.004591803,0.04168361,0.007417884,0.1089403,0.2091813],"study_design_scores_gemma":[0.01255499,0.0007160387,0.6375237,0.001569157,0.00009016876,0.000001416729,0.002698467,0.1402684,0.01944688,0.004058366,0.1804001,0.0006722026],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7402714,0.0276366,0.009958549,0.2083672,0.003169447,0.00753949,0.00286253,0.00004117438,0.0001535773],"genre_scores_gemma":[0.9962121,0.0002367466,0.001649139,0.001784947,0.00001924168,0.00005409235,0.000008142461,0.000007619046,0.00002794262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2559407,"threshold_uncertainty_score":0.8696753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1012791563851129,"score_gpt":0.2873647926583867,"score_spread":0.1860856362732737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}